Nu Skin Enterprises, Inc.
NUS
$8.48
-$0.09-1.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 209.28% | 206.20% | 167.92% | -1,063.13% | -1,805.57% |
| Total Depreciation and Amortization | -25.14% | -22.44% | -14.19% | -9.39% | 0.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -128.85% | -123.67% | -119.52% | -22.23% | 77.02% |
| Change in Net Operating Assets | -145.70% | -60.62% | -1.90% | 69.52% | 65.31% |
| Cash from Operations | -28.15% | -36.16% | -41.52% | -24.45% | -5.81% |
| Capital Expenditure | 17.57% | 26.90% | 34.00% | 27.66% | 28.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 209.69% | -4.89% | 47.72% | -73.24% | 186.47% |
| Cash from Investing | 549.56% | 519.75% | 477.34% | 218.42% | 71.78% |
| Total Debt Issued | 266.67% | 266.67% | -- | -83.33% | -86.36% |
| Total Debt Repaid | -77.69% | -197.71% | -355.62% | -759.38% | -868.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -965.05% | -416.03% | 58.60% | 58.04% | 84.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.78% | 57.78% | 73.32% | 80.48% | 84.63% |
| Other Financing Activities | 157.46% | 147.16% | 119.25% | 76.22% | -- |
| Cash from Financing | -51.98% | -107.19% | -92.14% | -1,083.44% | -1,341.16% |
| Foreign Exchange rate Adjustments | 132.76% | -221.18% | 188.58% | 70.29% | -176.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.81% | 532.07% | 453.05% | 49.67% | -698.04% |